Stephanie Culler from Persephone Biosciences highlights the rising gut microbial imbalance in babies, which makes them more vulnerable to chronic diseases.



Summary

Stephanie Culler, CEO of Persephone Biosciences, emphasizes the growing issue of gut microbiome dysbiosis in infants. This imbalance, often stemming from factors like C-sections and antibiotic use, leaves babies increasingly susceptible to developing chronic diseases later in life. Culler’s work focuses on understanding and addressing this critical early-life gut health vulnerability to improve long-term health outcomes for children. Persephone Biosciences is actively researching and developing potential interventions to restore and maintain a healthy gut microbiome in infants.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer